CS1
Pre-clinicalActive 0 watching 0 views this week💤 Quiet
18
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Pulmonary Arterial Hypertension
Conditions
Pulmonary Arterial Hypertension
Trial Timeline
— → —
NCT ID
NCT06321705About CS1
CS1 is a pre-clinical stage product being developed by Cereno Scientific for Pulmonary Arterial Hypertension. The current trial status is active. This product is registered under clinical trial identifier NCT06321705. Target conditions include Pulmonary Arterial Hypertension.
Hype Score Breakdown
Clinical
5
Activity
2
Company
5
Novelty
2
Community
1
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT06321705 | Pre-clinical | Active |
Competing Products
20 competing products in Pulmonary Arterial Hypertension